Eli Lilly and Co.'s drug Portrazza was approved by the Food and Drug Administration (FDA) Nov. 24 as a combination treatment for advanced squamous non-small cell lung cancer (NSCLC). Read More »

Biotechnology company Pieris Pharmaceuticals announced Monday that it received a milestone payment of an undisclosed amount from Sanofi for the continuous advancement of the tetraspecific Anticalin-based program for infectious disease. Read More »

CVS announced Monday that Repatha will be the only PCSK9 inhibitor added to its market.  Read More »

Recent doctor of pharmacy graduates can now learn how to become independent community pharmacy owners with the University of North Carolina at Chapel Hill (UNC)-Eshelman School of Pharmacy's recently launched pharmacy residency program. Read More »

The Children’s Hospital of Philadelphia (CHOP) is working with health care provider Aetna to improve the quality of health care and reduce costs. Read More »

Thomas Reuters recently named research-driven pharmaceutical company Boehringer Ingelheim a leader in innovation. Read More »

AstraZeneca entered into three partnerships Nov. 20 aimed at expanding technology capabilities at its new research facility on the Cambridge Biomedical Campus in England. Read More »

Missouri residents will now have access to more MinuteClinics as new locations were recently opened in Springfield. Read More »

National Community Pharmacist Association (NCPA) President Bradley Arthur provided testimony Nov. 17 on the dominating power that large pharmacy benefit management (PBM) corporations have on the pharmaceutical marketplace. Read More »

Cigna announced Monday it has expanded its health offerings in Missouri by making its Medicare Advantage health plan available to Kansas City residents. Read More »

CVS Health introduced various digital tools Nov. 18 in order to make health management easier and more efficient for its customers. Read More »

More than 200 members of the American Society of Health-System Pharmacists (ASHP) recently approved three professional policies at the organization's inaugural virtual House of Delegates. Read More »

AstraZeneca Pharmaceutical's Tagrisso was approved by the Food and Drug Administration (FDA) Nov. 13 as a treatment for advanced non-small cell lung cancer (NSCLC). Read More »

The National Association of Chain Drug Stores (NACDS) joined the Centers for Disease Control and Prevention (CDC) in commemorating the recent Get Smart about Antibiotics Week. Read More »

The Phoenix Business Journal honored Avella Specialty Pharmacy with two Arizona Corporate Excellence (ACE) Awards Nov. 12. Read More »

The Food and Drug Administration (FDA) accepted Accu-Break Pharmaceutical's New Drug Application (NDA) for warfarin potassium Thursday. Read More »

Janssen Research & Development submitted an application to the Food and Drug Administration (FDA) Friday for the approval of Invokamet as an adjunctive treatment in adults with type 2 diabetes. Read More »

The Food and Drug Administration (FDA) approved the first nasal spray version of naloxone Wednesday as an emergency life-saving treatment for opioid overdose. Read More »

Biopharmaceutical company AstraZeneca recently agreed to sell the U.S. rights to its Crohn's disease drug Entocort to Perrigo Company for $380 million. Read More »

Pfizer and Allergan, two of the biggest names in the pharmaceutical industry, announced that they are merging today as part of a deal valued at approximately $160 billion.  Read More »